Results 241 to 250 of about 509,257 (301)

Clinical prognostic risk model optimization based on vascular density in neuroblastoma

open access: yesPediatric Investigation, EarlyView.
This study integrates lymphatic vessel density with the International Neuroblastoma Risk Group (INRG) risk classification to develop a more accurate clinical prognostic model for neuroblastoma, demonstrating superior discrimination, calibration, and clinical net benefit compared with the INRG risk classification alone.
Qiaoyin Liu   +15 more
wiley   +1 more source

Distinct Role of Dural and Leptomeningeal Macrophages in Maintaining Cerebrospinal Fluid Drainage to Meningeal Lymphatic Vessels. [PDF]

open access: yesAm J Pathol
Lohat V   +9 more
europepmc   +1 more source

Proteomic Analysis of Mixed Cell Membrane Extracts From Triple‐Negative Breast Cancer Cell Lines Revealed Broad Metabolic Reprogramming Associated With Tumor Progression

open access: yesPROTEOMICS, EarlyView.
ABSTRACT Triple‐negative breast cancer (TNBC) represents the most aggressive subtype with limited therapeutic options and the poorest clinical outcomes. Using high‐resolution nUPLC‐QTOF‐MS/MS, we performed comprehensive proteomic profiling of TNBC cell lines representing disease progression stages: HCC‐1937 (stage IIB), HCC‐1599 (stage IIIA), and MDA ...
Claudia Sissely Chaviano‐Montes de Oca   +7 more
wiley   +1 more source

Revealing the presence of lymphatic vessels within intervertebral discs: Novel insights into disc degeneration. [PDF]

open access: yesInnovation (Camb)
Zou F   +22 more
europepmc   +1 more source

Emerging Approaches for Phytoconstituent Delivery in the Management of Rheumatoid Arthritis: Bridging Nature and Nanotechnology

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Rheumatoid arthritis (RA) is an autoimmune condition marked by joint inflammation, cartilage destruction, and bone damage. Conventional treatments, including NSAIDs and DMARDs, have shown effectiveness in slowing down disease progression, but prolonged exposure to such medications results in adverse effects and lack of tolerance among patients.
Yogesh Khairnar   +5 more
wiley   +1 more source

Lymphatic vessels in the age of cancer immunotherapy. [PDF]

open access: yesNat Rev Cancer
Karakousi T, Mudianto T, Lund AW.
europepmc   +1 more source

Multi-parameter tunable synthetic matrix for engineering lymphatic vessels. [PDF]

open access: yesCommun Biol
Alderfer L   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy